Simple jQuery Dropdowns

Browsing by Author GlaxoSmithKline plc, United Kingdom

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
20-Mar-20031,2-Cyclic sulfamidates as versatile precursors to thiomorpholines and piperazinesAndrew J. Williams; Suda Chakthong; Diane Gray; Ron M. Lawrence; Timothy Gallagher; University of Bristol; GlaxoSmithKline plc, United Kingdom; Chulabhorn Research Institute; Mahidol University
1-May-2008Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in ThailandSomporn Srifuengfung; Chanwit Tribuddharat; Preecha Champreeda; Justin Daniels; Kulkanya Chokephaibulkit; Nithita Wongwan; Pitimon Polwichai; Department of Microbiology; GlaxoSmithKline plc, United Kingdom; Mahidol University; Faculty of Medicine, Siriraj Hospital, Mahidol University
1-Jul-2004Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudinePedro Cahn; Asda Vibhagool; Mauro Schechter; Luis Soto-Ramirez; Giampiero Carosi; Fiona Smaill; Jamie C. Jordan; Cristina E. Pharo; Nicola E. Thomas; Helen M. Steel; Fundacion Huesped; Mahidol University; Universidade Federal do Rio de Janeiro; Instituto Nacional de la Nutricion Salvador Zubiran; Universita degli Studi di Brescia; McMaster University Medical Centre; GlaxoSmithKline, USA; GlaxoSmithKline plc, United Kingdom
1-Sep-2002Remifentanil vs morphine for patients in Intensive Care Unit who need short-term mechanical ventilationThitima Chinachoti; Peter Kessler; Andrew Kirkham; Thewarug Werawatganon; Mahidol University; Goethe-Universitat Frankfurt am Main; GlaxoSmithKline plc, United Kingdom; Chulalongkorn University
1-Jul-2004Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: Results of a 48-week open-label, equivalence trial (CNA3014)Asda Vibhagool; Pedro Cahn; Mauro Schechter; Fiona Smaill; Luis Soto-Ramirez; Giampiero Carosi; Maria Montroni; Cristina E. Pharo; Jamie C. Jordan; Nicola E. Thomas; Gill Pearce; Mahidol University; Fundacion Huesped; Universidade Federal do Rio de Janeiro; McMaster University Medical Centre; Instituto Nacional de la Nutricion Salvador Zubiran; Clin. Malat. Infettive e Tropicalli; Ospedale Umberto I, Ancona; GlaxoSmithKline plc, United Kingdom; GlaxoSmithKline, USA